ArticleCell death & disease2024

Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.

Benjamin Ziman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.